Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
RefMet: Reference List of Metabolite Names
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Clustering data with hclust algorithm for (Study ST001795)
(Analysis AN002915)
Metabolite
Structure
F1
F2
F3
1-O-Octadec-9-enyl glycerol
ME416429
0.90
0.19
1.96
di-n-Undecylamine
ME416427
1.06
0.04
1.43
Tridemorph
ME416707
1.08
0.13
1.69
PC 42:11
ME416634
0.92
NA
1.06
Minabeolide-2
ME416423
0.88
NA
1.08
Pleuromutilin
ME416669
0.90
NA
1.07
[SP amino_dimethyl(18:0)] 2-amino-14_16-dimethyloctadecan-3-ol
ME416422
0.81
NA
1.13
Spisulosine
ME416701
0.77
NA
1.15
PC 40:1
ME416625
1.06
0.13
1.13
PA P-28:0 or PA O-28:1
ME416590
1.07
0.02
1.04
PA 44:1
ME416584
0.95
NA
1.05
PA 36:0
ME416578
0.96
NA
1.04
PA 42:1
ME416582
0.97
NA
1.03
PS P-42:5 or PS O-42:6
ME416681
0.99
NA
1.01
PS O-18:0
ME416674
0.99
NA
1.01
PA 40:1
ME416580
0.99
NA
1.01
PC 24:0
ME416601
0.99
NA
1.01
PC 28:0
ME416602
1.01
NA
0.99
PC 30:2
ME416605
1.01
NA
0.99
Erucicoyl-EA
ME416543
1.03
NA
0.98
PC 42:1
ME416633
1.03
NA
0.98
N-(2-hydroxyoctadecanoyl)-sphinganine
ME416426
1.02
NA
0.98
PA 38:0
ME416579
1.02
NA
0.98
PS P-36:0 or PS O-36:1
ME416676
1.15
0.04
0.96
MG(0:0/22:2(13Z_16Z)/0:0)
ME416425
1.10
NA
0.90
PA 22:0/0:0*
ME416574
1.10
NA
0.90
PA 34:0
ME416577
1.08
NA
0.92
PS O-16:0/22:1(11Z)*
ME416673
1.05
NA
0.95
PA 17:0/14:1*
ME416573
1.07
NA
0.93
LPC 12:0
ME416547
1.06
NA
0.94
N-(2-hydroxyundecanoyl)-phytosphingosine
ME416424
1.06
NA
0.94
PC(16:0/9:0(CHO))
ME416450
1.46
0.49
1.00
PS P-29:0 or PS O-29:1
ME416675
1.45
0.36
1.05
PC 30:1
ME416604
1.34
0.08
1.37
PC 36:1
ME416616
1.34
0.11
1.45
Cer 18:0;O3/15:0;O
ME416527
1.37
0.15
1.20
1-Dodecanoyl-sn-glycerol
ME416428
1.48
0.13
1.29
FA oxo(15:0)
ME416431
1.42
0.21
1.28
PC 38:1
ME416621
1.29
0.24
1.39
PC 34:1
ME416611
1.31
0.27
1.33
PC 30:0
ME416603
1.33
0.25
1.34
PE 40:6
ME416661
1.33
0.24
1.34
PA P-30:0 or PA O-30:1
ME416591
1.25
0.19
1.20
SM 18:1;O2/24:0
ME416685
1.22
0.20
1.22
PA P-34:0 or PA O-34:1
ME416594
1.25
0.17
1.30
PS P-38:1 or PS O-38:2
ME416678
1.29
0.13
1.28
Cer 18:0;O3/13:0;O
ME416526
1.35
0.06
1.06
PA O-28:0
ME416586
1.21
0.25
1.12
PC 32:3
ME416609
1.32
0.24
1.11
PS P-38:2 or PS O-38:3
ME416679
1.15
0.56
1.00
Cer 36:1;O2
ME416534
1.14
0.46
0.98
PC P-40:0 or PC O-40:1
ME416656
1.20
0.46
1.04
Cer 18:0;O2/16:0
ME416522
1.28
0.55
1.11
Cer 18:1;O2/16:0
ME416528
1.24
0.63
1.09
[FA (16:2)] N-hexadecyl-ethanolamine
ME416452
1.24
0.58
1.13
LPC 14:0
ME416548
1.26
0.59
1.11
PC O-34:0
ME416643
1.24
0.60
1.11
PC 34:0
ME416610
1.32
0.61
1.03
[ST (3:0)] cholest-5Z_7Z_24-trien-3beta-ol
ME416459
1.28
0.66
1.02
3-beta-Hydroxy-4-beta-methyl-5-alpha-cholest-7-ene-4-alpha-carboxylate
ME416509
1.22
0.67
1.06
PC 32:0
ME416606
1.22
0.67
1.07
PA P-30:1 or PA O-30:2
ME416592
1.17
0.63
1.04
PS P-36:1 or PS O-36:2
ME416677
1.20
0.65
0.99
PA 40:3
ME416581
1.19
0.41
1.13
N-(2-hydroxyeicosanoyl)-sphinganine
ME416430
1.07
0.37
1.16
PS(P-20:0/22:2(13Z_16Z))
ME416432
1.07
0.45
1.18
Glucosylceramide
ME416437
1.03
0.53
1.28
PC 42:9
ME416640
1.04
0.51
1.34
GlcCer 14:1;O2(4E)/20:0;O
ME416544
1.09
0.53
1.33
Stearamide
ME416702
1.09
0.51
1.34
1-(14-methyl-pentadecanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerol
ME416441
1.17
0.51
1.26
SM 36:2;O2
ME416693
1.17
0.51
1.26
FA oxo(21:0)
ME416439
1.16
0.51
1.22
CAR 16:0
ME416519
1.20
0.51
1.23
Cer 18:1;O2/24:0
ME416529
1.18
0.53
1.23
Cer 40:1;O2
ME416535
1.23
0.50
1.21
[SP hydroxy(16:0)] N-(hexadecanoyl)-4S-hydroxysphinganine
ME416446
1.20
0.55
1.20
N-(2-hydroxynonadecanoyl)-phytosphingosine
ME416443
1.23
0.53
1.18
[PC(18:3)]
ME416448
1.25
0.55
1.15
Glucosylceramide (d18:1/22:0)
ME416445
1.12
0.57
1.26
PC 36:3
ME416618
1.14
0.56
1.26
anhydroretinol
ME416442
1.06
0.60
1.26
Glucosylceramide (d18:1/16:0)
ME416444
1.09
0.58
1.29
Cer 18:0;O2/24:0;O
ME416525
1.17
0.60
1.18
[ST Oxo(2:0)] 3-Oxochola-4_6-dien-24-oic Acid
ME416449
1.16
0.58
1.22
PC 36:2
ME416617
1.14
0.63
1.20
LPC 24:0
ME416560
1.11
0.62
1.22
PC 42:5
ME416637
1.09
0.60
1.22
PC 40:9
ME416632
1.12
0.26
1.29
PC 34:4
ME416614
1.25
0.34
1.34
Cer 18:0;O2/22:0
ME416523
1.21
0.35
1.37
PC 38:2
ME416622
1.22
0.38
1.34
PC 38:5
ME416624
1.17
0.41
1.35
PC 40:7
ME416630
1.18
0.40
1.36
PC 36:4
ME416619
1.18
0.45
1.31
Cer 18:0;O2/24:0
ME416524
1.14
0.47
1.33
PC 42:7
ME416638
1.15
0.46
1.34
PC 32:2
ME416608
1.32
0.47
1.15
PA P-34:1 or PA O-34:2
ME416595
1.31
0.31
1.30
PC 32:1
ME416607
1.33
0.31
1.28
Octadecadienal
ME416435
1.38
0.32
1.22
PE 40:7
ME416662
1.35
0.35
1.23
N-(2-hydroxydocosanoyl)-sphinganine
ME416440
1.23
0.46
1.25
PC 34:3
ME416613
1.23
0.43
1.28
PC P-36:0 or PC O-36:1
ME416648
1.31
0.42
1.21
CAR 18:1
ME416521
1.28
0.37
1.28
PC 36:5
ME416620
1.30
0.35
1.28
PC 36:0
ME416615
1.27
0.40
1.26
PC P-38:0 or PC O-38:1
ME416652
1.29
0.40
1.24
Tris(butoxyethyl)phosphate
ME416438
0.88
0.55
1.52
CTAB
ME416433
1.05
0.36
1.52
FA oxo(14:1) cyclopentanebutanoic acid
ME416434
0.98
0.40
1.55
[PC(22:6/22:6)] 1_2-di-(4Z_7Z_10Z_13Z_16Z_19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine
ME416436
1.12
0.40
1.42
PC 40:5
ME416629
1.06
0.43
1.44
PC 40:8
ME416631
1.08
0.42
1.44
PC 38:4
ME416623
1.18
0.31
1.44
Docosanamide
ME416541
1.14
0.33
1.46
Phytosphingosine
ME416668
1.11
0.32
1.49
SM 33:1;O2
ME416688
0.70
1.36
0.98
10_11-Dihydro-12R-hydroxy-leukotriene E4
ME416447
0.93
1.37
0.95
all-trans-13_14-Dihydroretinol
ME416489
0.92
1.25
0.86
[SP (3:0)] sphinga-4E_8E_10E-trienine
ME416487
0.91
1.24
0.88
PC 18:2
ME416599
0.86
1.32
0.86
LPC 18:1
ME416552
0.88
1.29
0.86
SM 39:1;O2
ME416696
0.90
1.29
0.84
Arachidonoyl-EA
ME416514
0.81
1.32
0.90
Magnoshinin
ME416568
0.81
1.25
0.98
LPC 22:5
ME416559
0.87
1.22
0.93
SM 18:2;O2/22:1
ME416686
0.86
1.26
0.91
PC O-20:0
ME416641
0.93
1.32
0.78
14:4(2E_4E_8E_10E)(6Me[S]_9Me_12Me[S])
ME416492
0.91
1.35
0.74
14^-apo-beta-Carotenal
ME416507
0.92
1.35
0.76
PC P-36:4 or PC O-36:5
ME416651
0.76
1.46
0.83
LPC 20:0
ME416553
0.86
1.39
0.79
5beta-cholestan-3alpha_4alpha_11beta_12beta_21-pentol-3_21-disulphate
ME416490
0.82
1.43
0.82
SM 41:1;O2
ME416699
0.79
1.40
0.85
SM(d17:1/24:1(15Z))
ME416491
0.83
1.38
0.83
LPE 20:2
ME416565
0.80
1.49
0.77
4-Dodecylphenol
ME416511
0.85
1.48
0.73
CAR 14:0
ME416517
0.83
1.47
0.75
Retinol
ME416683
0.88
1.48
0.69
3_5_7-Trimethyl-2E_4E_6E_8E-decatetraene
ME416493
0.91
1.44
0.69
Eicosanoyl-EA
ME416542
0.92
1.41
0.71
Cer 35:0;O2
ME416533
1.23
1.25
0.52
Tributyl phosphate
ME416705
1.15
1.18
0.69
CAR 14:1
ME416518
1.11
1.12
0.78
Margaroyl-EA
ME416569
1.11
1.16
0.75
FA oxo(19:0)
ME416494
1.03
1.42
0.60
beta-Estradiol
ME416515
1.03
1.32
0.69
Retinal
ME416682
1.00
1.36
0.64
3Z_6Z_9Z-Tricosatriene
ME416476
0.83
0.84
1.50
PC 42:2
ME416635
0.88
1.08
1.05
PE 42:3
ME416663
0.84
1.13
1.05
Cer 33:1;O2
ME416532
0.86
1.14
1.02
SM 35:1;O2
ME416691
0.88
1.12
1.01
DG 42:9
ME416540
0.81
1.03
1.13
PE 42:4
ME416664
0.78
1.13
1.11
PA O-34:0
ME416589
1.09
0.88
0.98
SM 40:1;O2
ME416697
1.11
0.90
0.98
SM 42:3;O2
ME416700
1.08
0.88
1.02
SM(d18:1/24:1(15Z))
ME416469
1.06
0.90
1.03
ubiquinol-1
ME416470
0.97
0.95
1.08
LPC 16:1(9Z)*
ME416550
0.97
0.97
1.06
PA O-32:0
ME416588
0.95
0.96
1.07
PC P-36:3 or PC O-36:4
ME416650
0.95
0.97
1.07
PC P-22:3 or PC O-22:4
ME416644
1.02
0.96
1.01
PA P-32:1 or PA O-32:2
ME416593
1.03
0.95
1.01
PA P-34:2 or PA O-34:3
ME416596
1.03
0.95
1.02
N-(2-hydroxy-docosanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine
ME416472
1.02
0.94
1.04
Cer 41:1;O2
ME416537
1.00
0.95
1.04
[ST] (5Z_7E)-9_10-seco-5_7_10(19)-cholestatriene
ME416473
1.00
0.96
1.04
Tremetone
ME416704
1.01
0.88
1.09
8-hydroxy-13Z-octadecene-9_11-diynoic acid
ME416467
1.03
0.90
1.05
Phenylpyruvic acid
ME416667
1.01
0.92
1.06
Falcarindiol
ME416488
1.00
1.19
0.83
LPC 20:2
ME416555
0.93
1.14
0.94
[PI(18:1)] 1-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1^-myo-inositol)
ME416485
0.98
1.15
0.89
[SP] (3^-sulfo)Galbeta-Cer(d18:0/2-OH-18:0)
ME416484
0.97
1.15
0.90
Cholestenone
ME416538
0.94
1.18
0.90
LPC P-18:1 or LPC O-18:2
ME416562
0.95
1.19
0.89
PC P-38:1 or PC O-38:2
ME416653
0.96
1.03
1.01
SP (4:0)
ME416474
0.97
1.03
1.01
Cer 41:0;O2
ME416536
0.95
1.05
1.01
SM 40:2;O2
ME416698
0.94
1.04
1.02
Estradiol-17-phenylpropionate
ME416481
0.99
1.08
0.94
LPC 20:1
ME416554
0.98
1.11
0.92
LPC 16:0
ME416549
1.00
1.04
0.97
4-8dimethylnonanoylcarnitine
ME416479
1.00
1.05
0.96
Linoleamide
ME416546
1.00
1.05
0.96
[FA hydroxy(20:4)] eicosatetraenoyl amine
ME416480
0.97
1.07
0.97
PC P-36:1 or PC O-36:2
ME416649
0.96
1.08
0.97
2-Aminotetradecanoic acid
ME416508
1.10
1.07
0.84
PA 44:6
ME416585
1.07
1.00
0.93
N-(2-hydroxyoctadecanoyl)-phytosphingosine
ME416465
1.08
0.98
0.94
Phencyclidine
ME416666
1.09
0.99
0.92
PC 22:1
ME416600
1.04
1.03
0.93
Xestoaminol C
ME416708
1.02
1.06
0.93
LPE 16:0
ME416563
1.04
1.08
0.89
PA 42:10
ME416583
1.07
1.04
0.90
(1R_4S)-fenchan-2-one
ME416478
1.14
0.96
0.90
N-(2-hydroxyicosanoyl)-phytosphingosine
ME416455
1.15
0.91
0.89
4_8-Dimethyl-1_3E_7-nonatriene
ME416477
1.16
0.94
0.89
FA (14:2) tetradecadienal
ME416475
1.17
0.92
0.90
MG 14:0
ME416570
1.25
0.75
0.97
SM(d18:0/24:1(15Z))
ME416466
1.23
0.77
0.98
Cer 18:1;O2/24:1
ME416530
1.15
0.80
1.02
PC(o-22:0/20:4(8Z_11Z_14Z_17Z))
ME416454
1.14
0.76
1.02
PC P-42:4 or PC O-42:5
ME416660
1.14
0.84
1.00
[FA (18:2)] 3Z_13Z-octadecadien-1-ol
ME416468
1.17
0.84
0.97
Hexadecenal
ME416471
1.19
0.85
0.94
PC 42:8
ME416639
0.98
0.64
1.34
1-eicosanoyl-(1-cyano-2-methylprop-2-en-1-ol)
ME416453
0.98
0.70
1.28
PS 17:1
ME416671
0.98
0.67
1.31
PC 40:3
ME416627
1.16
0.66
1.14
SM 36:1;O2
ME416692
1.15
0.71
1.11
Tridecylic acid
ME416706
1.15
0.74
1.08
Glucosylceramide (d18:1/24:1(15Z))
ME416456
1.06
0.70
1.21
SM 18:0;O2/16:0
ME416684
1.07
0.68
1.22
Himbacine
ME416458
1.06
0.74
1.17
PC P-40:3 or PC O-40:4
ME416659
1.05
0.75
1.17
PS P-40:2 or PS O-40:3
ME416680
1.02
0.74
1.19
SM 34:1;O2
ME416689
1.03
0.76
1.18
PC 40:4
ME416628
1.04
0.74
1.19
SM 38:1;O2
ME416694
1.04
0.75
1.18
PS 34:0
ME416672
1.01
0.85
1.14
PC P-40:2 or PC O-40:3
ME416658
1.03
0.80
1.15
haematoporphyrin IX
ME416462
1.04
0.81
1.14
SM 38:2;O2
ME416695
1.03
0.81
1.14
PA O-30:0
ME416587
1.03
0.80
1.11
N-Acetyl-beta-glucosaminylamine
ME416571
1.05
0.82
1.11
PC 34:2
ME416612
1.05
0.82
1.11
PC P-32:0 or PC O-32:1
ME416645
1.03
0.82
1.13
PC P-38:2 or PC O-38:3
ME416654
1.04
0.82
1.12
PC O-32:0
ME416642
1.07
0.80
1.11
SM 34:2;O2
ME416690
1.08
0.81
1.09
3_5_7-Trimethyl-2E_4E_6E_8E-undecatetraene
ME416463
1.11
0.80
1.06
LPC 24:1(15Z)*
ME416561
1.10
0.80
1.08
PC P-40:1 or PC O-40:2
ME416657
1.10
0.79
1.09
LPC 22:0
ME416558
1.09
0.73
1.15
PC P-38:4 or PC O-38:5
ME416655
1.07
0.77
1.14
LPC 20:3
ME416556
1.08
0.76
1.13
LPC 20:4
ME416557
1.09
0.77
1.12
acyl phosphatidylglycerol (n-C12:0)
ME416460
1.13
0.74
1.11
9_12-Hexadecadienoylcarnitine
ME416461
1.11
0.76
1.10
PC P-34:0 or PC O-34:1
ME416646
1.11
0.76
1.11
LPC 18:0
ME416551
1.10
0.75
1.12
Oleamide
ME416572
1.10
0.74
1.13
Hymenoflorin
ME416545
0.91
0.91
1.27
PE 42:6
ME416665
0.97
0.87
1.14
N_N-Dimethylsphing-4-enine
ME416464
0.95
0.89
1.14
PC 40:2
ME416626
0.96
0.88
1.15
alpha-Linolenoyl-EA
ME416512
0.96
0.82
1.20
(9S_10S)-10-Hydroxy-9-(phosphonooxy)octadecanoate
ME416451
0.93
0.79
1.19
PC 42:4
ME416636
0.97
0.78
1.18
N-(5-hydroxy-pentyl)-5Z_8Z_11Z_14Z-eicosatetraenoyl amine
ME416457
0.92
0.77
1.29
SM 32:1;O2
ME416687
0.96
0.77
1.25
Altretamine
ME416513
1.83
0.78
0.37
Burseran
ME416516
1.79
0.88
0.33
Dihydroceramide
ME416486
1.23
1.02
0.75
[SP hydroxy_hydroxy_methyl(10:2/2:0)] 6R-(8-hydroxydecyl)-2R-(hydroxymethyl)-piperidin-3R-ol
ME416483
1.25
0.98
0.77
3-Dimethylallyl-4-hydroxymandelic acid
ME416482
1.34
0.91
0.75
CAR 16:1;OH
ME416520
1.41
0.89
0.68
Cer 33:0;O2
ME416531
1.53
0.95
0.52
Tetrapentylammonium
ME416703
1.51
1.19
0.48
[SP dimethyl_amino(18:0/2:0)] 2S-dimethylaminooctadecane-1_3R-diol
ME416505
0.56
1.22
NA
PA 30:3
ME416576
0.64
1.63
0.59
[FA (17:1)] 7-heptadecynoic acid
ME416495
0.66
1.76
0.67
LPE 20:0
ME416564
0.65
1.78
0.66
PC P-34:1
ME416647
0.64
1.79
0.66
Coniferyl alcohol
ME416539
0.68
1.70
0.70
3-Ketosphingosine
ME416510
0.70
1.67
0.70
LPE 22:1
ME416567
0.73
1.66
0.69
PA P-34:3 or PA O-34:4
ME416597
0.79
1.58
0.70
7_10_13_16-Docosatetraenoylethanolamine
ME416496
0.86
1.62
0.58
PA P-34:4 or PA O-34:5
ME416598
0.76
1.68
0.56
Antibiotic TA
ME416500
0.37
1.93
0.57
N-(11Z_14Z-eicosadienoyl)-ethanolamine
ME416501
0.57
2.15
0.40
[SP methyl(2:0)] 9-methyl-sphinga-4E_8E-dienine
ME416499
0.59
2.05
0.47
Sphinganine(d17:0)Ê
ME416498
0.72
1.89
0.49
Noladin Ether
ME416497
0.59
1.94
0.53
PA 26:0
ME416575
0.60
1.89
0.61
16alpha-Hydroxysteroid
ME416504
0.19
2.89
0.13
[FA methyl(18:0)] 9_10-methylene-9-octadecenoic acid
ME416503
0.43
2.42
0.31
LPE 22:0
ME416566
0.40
2.31
0.43
[FA (17:3)] 8Z_11Z_14Z-heptadecatrienoic acid
ME416502
0.40
2.37
0.38
Prosopinine
ME416670
0.41
2.35
0.39
Factors:
F1
Treatment:Celecoxib_HFD
F2
Treatment:CFD
F3
Treatment:HFD
Data matrix
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
Terms of use
Site map
Contact
NMDR Personnel